{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T23:39:01Z","timestamp":1718753941541},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/mot.0b013e328364fd93","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T16:13:16Z","timestamp":1377879196000},"page":"595-600","source":"Crossref","is-referenced-by-count":8,"title":["The role of immunological biomarkers in cardiac rejection"],"prefix":"10.1097","volume":"18","author":[{"given":"Clara","family":"Crescioli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20211004","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2011.08.003","article-title":"The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report-2011.","volume":"30","author":"Stehlik","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R2-16-20211004","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.trsl.2012.01.018","article-title":"Biomarkers of heart transplant rejection: the good, the bad, and the ugly!.","volume":"159","author":"Labarrere","year":"2012","journal-title":"Transl Res"},{"key":"R3-16-20211004","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.surge.2010.11.023","article-title":"Cardiac allograft rejection.","volume":"9","author":"Patel","year":"2011","journal-title":"Surgeon"},{"key":"R4-16-20211004","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.healun.2010.05.020","article-title":"Myeloperoxidase and carbonyl proteins: promising markers for noninvasive monitoring of graft rejection after heart transplantation.","volume":"29","author":"Koestenbauer","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R5-16-20211004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e318218e978","article-title":"Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation.","volume":"92","author":"Heidt","year":"2011","journal-title":"Transplantation"},{"key":"R6-16-20211004","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"R7-16-20211004","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MOT.0b013e32834ee402","article-title":"Immunologic monitoring in transplantation revisited.","volume":"17","author":"Cravedi","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"R8-16-20211004","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.healun.2009.05.041","article-title":"Soluble CD30 levels in recipients undergoing heart transplantation do not predict posttransplant outcome.","volume":"28","author":"Ypsilantis","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R9-16-20211004","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1097\/00007890-200005270-00023","article-title":"Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection.","volume":"69","author":"Schowengerdt","year":"2000","journal-title":"Transplantation"},{"key":"R10-16-20211004","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0966-3274(02)00072-2","article-title":"Evaluation of peripheral blood CD4 and CD8 lymphocyte subsets, CD69 expression and histologic rejection grade as diagnostic markers for the presence of cardiac allograft rejection.","volume":"10","author":"Creemers","year":"2002","journal-title":"Transpl Immunol"},{"key":"R11-16-20211004","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.healun.2009.12.015","article-title":"Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocyte.","volume":"29","author":"Kobashigawa","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R12-16-20211004","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/gm253","article-title":"Biomarkers in solid organ transplantation: establishing personalized transplantation medicine.","volume":"3","author":"Roedder","year":"2011","journal-title":"Genome Med"},{"key":"R13-16-20211004","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.transproceed.2011.06.044","article-title":"Assessment of immunological markers as mediators of graft vasculopathy development in heart transplantation.","volume":"43","author":"Mirabet","year":"2011","journal-title":"Transplant Proc"},{"key":"R14-16-20211004","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/MOT.0b013e328332bd4a","article-title":"Memory T-cell-specific therapeutics in organ transplantation.","volume":"14","author":"Page","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"R15-16-20211004","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/TP.0b013e31820f0856","article-title":"Memory T cells migrate to and reject vascularized cardiac allografts independent of the chemokine receptor CXCR3.","volume":"91","author":"Oberbarnscheidt","year":"2011","journal-title":"Transplantation"},{"key":"R16-16-20211004","first-page":"1046","article-title":"Serial measurement of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.","volume":"16","author":"George","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"R17-16-20211004","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cyto.a.20215","article-title":"Cytokine analysis to predict immunosuppression.","volume":"69","author":"Barten","year":"2006","journal-title":"Cytometry A"},{"key":"R18-16-20211004","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cca.2012.04.014","article-title":"Cytokines as predictive biomarkers of alloreactivity.","volume":"413","author":"Brunet","year":"2012","journal-title":"Clin Chim Acta"},{"key":"R19-16-20211004","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.athoracsur.2011.07.048","article-title":"Soluble ST2 is a marker for acute cardiac allograft rejection.","volume":"92","author":"Pascual-Figal","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R20-16-20211004","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/1354750X.2013.773081","article-title":"Interleukin receptor family member ST2 concentrations in patients following heart transplantation.","volume":"18","author":"Januzzi","year":"2013","journal-title":"Biomarkers"},{"key":"R21-16-20211004","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.cca.2012.02.009","article-title":"CXCL10: a candidate biomarker in transplantation.","volume":"413","author":"Romagnani","year":"2012","journal-title":"Clin Chim Acta"},{"key":"R22-16-20211004","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.4049\/jimmunol.0903831","article-title":"CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cells effectors.","volume":"184","author":"Rosemblum","year":"2010","journal-title":"J Immunol"},{"key":"R23-16-20211004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/TP.0b013e31823aa585","article-title":"Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection.","volume":"93","author":"Katuka","year":"2012","journal-title":"Transplantation"},{"key":"R24-16-20211004","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1097\/01.TP.0000069601.73079.94","article-title":"Chemokine and receptor gene expression during early and late acute rejection episodes in human cardiac allografts.","volume":"75","author":"Fahmy","year":"2003","journal-title":"Transplantation"},{"key":"R25-16-20211004","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00007890-200301150-00013","article-title":"Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants.","volume":"75","author":"Fahmy","year":"2003","journal-title":"Transplantation"},{"key":"R26-16-20211004","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1084\/jem.192.10.1515","article-title":"Requirement of the chemokine receptor CXCR3 for acute allograft rejection.","volume":"192","author":"Hancock","year":"2000","journal-title":"J Exp Med"},{"key":"R27-16-20211004","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.193.8.975","article-title":"Donor-derived IP-10 initiates development of acute allograft rejection.","volume":"193","author":"Hancock","year":"2001","journal-title":"J Exp Med"},{"key":"R28-16-20211004","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/TP.0b013e31819574e9","article-title":"CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival.","volume":"87","author":"Rosenblum","year":"2009","journal-title":"Transplantation"},{"key":"R29-16-20211004","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1600-6143.2008.02323.x","article-title":"The puzzling role of CXCR3 and its ligands in organ allograft rejection.","volume":"8","author":"Halloran","year":"2008","journal-title":"Am J Transplant"},{"key":"R30-16-20211004","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/TP.0b013e3181919f5d","article-title":"Predictive role of pretransplant serum CXCL10 for cardiac acute rejection.","volume":"87","author":"Crescioli","year":"2009","journal-title":"Transplantation"},{"key":"R31-16-20211004","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.4049\/jimmunol.169.3.1556","article-title":"Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.","volume":"3","author":"Zhao","year":"2002","journal-title":"J Immunol"},{"key":"R32-16-20211004","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/TP.0b013e31817b8e4b","article-title":"Prolongation of cardiac and islet allograft survival by blocking hamster antimouse CXCR3 monoclonal antibody.","volume":"86","author":"Uppaluri","year":"2008","journal-title":"Transplantation"},{"key":"R35-16-20211004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.02-0908fje","article-title":"Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop.","volume":"18","author":"Campbell","year":"2004","journal-title":"FASEB J"},{"key":"R36-16-20211004","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1161\/hc4601.098010","article-title":"Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection.","volume":"104","author":"Melter","year":"2001","journal-title":"Circulation"},{"key":"R37-16-20211004","first-page":"6","article-title":"Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.","volume":"19","author":"Karason","year":"2006","journal-title":"BMC Cardiovasc Disord"},{"key":"R38-16-20211004","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/j.1600-6143.2004.00525.x","article-title":"High pretransplant serum levels of CXCL10IP-10 are related to increased risk of renal allograft failure.","volume":"4","author":"Rotondi","year":"2004","journal-title":"Am J Transplant"},{"key":"R39-16-20211004","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.healun.2012.09.030","article-title":"VEGF-C and VEGF-A related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients.","volume":"32","author":"Daly","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R40-16-20211004","doi-asserted-by":"crossref","first-page":"e1002963","DOI":"10.1371\/journal.pcbi.1002963","article-title":"Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.","volume":"9","author":"Cohen Freue","year":"2013","journal-title":"PLoS Comput Biol"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201310000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T09:33:14Z","timestamp":1633512794000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201310000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e328364fd93","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}